Early Immune Signatures, Including TLR2 and TLR4 Expression, Associate with Complete Remission Following CD19 CAR-T Cell Therapy

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Vincenzo Giambra
DOI: 10.5281/zenodo.18244544
Cited by: 0

Fields of Study & Subjects

CAR-T cell therapy research Immunotherapy and Immune Responses T-cell and B-cell Immunology

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
14 January 2026